ZA201904371B - Compounds and compositions - Google Patents

Compounds and compositions

Info

Publication number
ZA201904371B
ZA201904371B ZA2019/04371A ZA201904371A ZA201904371B ZA 201904371 B ZA201904371 B ZA 201904371B ZA 2019/04371 A ZA2019/04371 A ZA 2019/04371A ZA 201904371 A ZA201904371 A ZA 201904371A ZA 201904371 B ZA201904371 B ZA 201904371B
Authority
ZA
South Africa
Prior art keywords
compounds
compositions
anions
carbon atoms
following formula
Prior art date
Application number
ZA2019/04371A
Other languages
English (en)
Inventor
Gaik Babikyan
Benjamin Jiaravanon
Original Assignee
Alectrona Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alectrona Pte Ltd filed Critical Alectrona Pte Ltd
Publication of ZA201904371B publication Critical patent/ZA201904371B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/20—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C219/22—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04—Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C07C227/08—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid by reaction of ammonia or amines with acids containing functional groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/38—Separation; Purification; Stabilisation; Use of additives
    • C07C227/40—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/12—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA2019/04371A 2017-01-10 2019-07-03 Compounds and compositions ZA201904371B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1700404.5A GB201700404D0 (en) 2017-01-10 2017-01-10 Compounds and composistions
PCT/SG2018/050012 WO2018132066A1 (en) 2017-01-10 2018-01-10 Compounds and compositions

Publications (1)

Publication Number Publication Date
ZA201904371B true ZA201904371B (en) 2024-09-25

Family

ID=58463756

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2019/04371A ZA201904371B (en) 2017-01-10 2019-07-03 Compounds and compositions

Country Status (19)

Country Link
US (1) US10858308B2 (enExample)
EP (1) EP3568203B1 (enExample)
JP (1) JP7069212B2 (enExample)
KR (1) KR102633466B1 (enExample)
CN (1) CN110382053B (enExample)
AR (1) AR113207A1 (enExample)
AU (1) AU2018207033B2 (enExample)
EA (1) EA039938B1 (enExample)
ES (1) ES2961572T3 (enExample)
GB (2) GB201700404D0 (enExample)
IL (1) IL267914B (enExample)
MX (1) MX390060B (enExample)
NZ (1) NZ755175A (enExample)
PL (1) PL3568203T3 (enExample)
SG (1) SG11201906173QA (enExample)
TW (1) TWI763763B (enExample)
UA (1) UA124435C2 (enExample)
WO (1) WO2018132066A1 (enExample)
ZA (1) ZA201904371B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3919476B1 (en) * 2019-02-01 2024-12-11 West China Hospital, Sichuan University Quaternary ammonium salt compound, preparation method therefor and use thereof
GB2584074B (en) 2019-04-16 2021-08-11 Alectrona Pte Ltd Monoterpene phenol derivatives
GB2601293B (en) * 2020-10-21 2023-05-31 Rhea Genetics Pte Ltd Monoterpene phenol derivatives for use in treating an infection caused by a coronavirus or African swine fever virus

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1258924A (enExample) * 1968-06-10 1971-12-30
GB1491878A (en) * 1974-02-28 1977-11-16 Agfa Gevaert Direct positive silver halide emulsions having incorporated developers
JP2905274B2 (ja) * 1989-11-08 1999-06-14 花王株式会社 新規ポリカチオン化合物及びこれを含有する漂白剤組成物
AU2003255460A1 (en) * 2002-08-27 2004-03-19 Ciba Specialty Chemicals Holding Inc. Method for delivering biologically active substances
JP2005162769A (ja) * 2003-11-28 2005-06-23 Canon Inc 水性インク
CN100343223C (zh) * 2005-03-07 2007-10-17 常州市智能动物药业有限公司 百里酚或香芹酚的酯类化合物、制备方法及其药物活性组合物
MX2017000447A (es) * 2014-07-11 2017-04-27 Genzyme Corp Poliaminas de cadena principal.
CN104959070A (zh) * 2015-06-19 2015-10-07 武汉工程大学 一种阳离子双子表面活性剂及其制备方法
CN105503631A (zh) 2015-12-25 2016-04-20 四川大学 一种可降解的双子季铵盐杀菌剂及其制备方法

Also Published As

Publication number Publication date
AR113207A1 (es) 2020-02-19
US10858308B2 (en) 2020-12-08
ES2961572T3 (es) 2024-03-12
EA201991350A1 (ru) 2020-04-13
GB201802344D0 (en) 2018-03-28
GB2562338C (en) 2019-09-18
EP3568203A1 (en) 2019-11-20
JP2020505443A (ja) 2020-02-20
GB2562338B (en) 2019-04-24
CN110382053A (zh) 2019-10-25
MX2019008319A (es) 2020-02-05
JP7069212B2 (ja) 2022-05-17
EP3568203C0 (en) 2023-09-13
SG11201906173QA (en) 2019-08-27
IL267914A (en) 2019-09-26
KR102633466B1 (ko) 2024-02-02
GB201700404D0 (en) 2017-02-22
NZ755175A (en) 2021-07-30
EA039938B1 (ru) 2022-03-30
KR20190104588A (ko) 2019-09-10
BR112019014223A2 (pt) 2020-03-17
EP3568203B1 (en) 2023-09-13
IL267914B (en) 2022-04-01
TWI763763B (zh) 2022-05-11
GB2562338A (en) 2018-11-14
CA3049369A1 (en) 2018-07-19
US20190352253A1 (en) 2019-11-21
AU2018207033A1 (en) 2019-07-25
WO2018132066A1 (en) 2018-07-19
PL3568203T3 (pl) 2024-02-26
MX390060B (es) 2025-03-20
AU2018207033B2 (en) 2023-07-20
UA124435C2 (uk) 2021-09-15
GB2562338A8 (en) 2018-12-19
TW201829370A (zh) 2018-08-16
CN110382053B (zh) 2022-11-01

Similar Documents

Publication Publication Date Title
ZA202206923B (en) New methylquinazolinone derivatives
EP4474017A3 (en) New heterocyclic compounds
PH12020500673A1 (en) Compounds
PH12018502535B1 (en) Substituted carbonucleoside derivatives useful as anticancer agents
ZA202403101B (en) Antiviral prodrugs and nanoformulations thereof
MX383935B (es) Amidas heterocíclicas como inhibidores de cinasa.
PH12020500236A1 (en) Heterocyclic compund and use thereof
PH12022550471A1 (en) Heterocyclic compounds
PH12019550224A1 (en) Antitumoral compounds
SG11201805286RA (en) α,β-UNSATURATED AMIDE COMPOUND
GEP20207111B (en) Heteroaryl compounds for kinase inhibition
MX2020014097A (es) Lipidos novedosos.
MX388612B (es) Intermediarios para preparar herbicidas de piridazinona y proceso para prepararlos.
MX388175B (es) Compuestos terapéuticos y métodos para utilizarlos
CR20220004A (es) Nuevos compuestos heterocíclicos
MX2020002449A (es) Nuevos compuestos heterociclicos fungicidas.
SG10201806809QA (en) 1-heterocyclyl isochromanyl compounds and analogs for treating cns disorders
EP4706394A3 (en) Use of alkoxypyrazoles as nitrification inhibitors
EA201991241A1 (ru) Способ получения метоксиметилпиридин дикарбоксилата
ZA202007737B (en) Pentacyclic compound
ZA202204442B (en) Salt forms of a complement component c5a receptor
ZA202205170B (en) Process and intermediate for the preparation of oxetan-2-ylmethanamine
GB2562338A (en) Compounds and compositions
MX386501B (es) Compuestos terapeuticos y sus metodos de uso
MX2021001904A (es) Formas solidas de benzoxaborol sustituido y composiciones de las mismas.